Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries

Melissa Matz | F Berrino | B Rachet | B Møller | S Rohrmann | F Merletti | W Mazzucco | Maja Nikšić | A Gos | P Contiero | G Tagliabue | Jacques Estève | R Tumino | A Gavin | S Siesling | G Carrozzi | I Oki | M Colonna | J Wang | Y H Li | X Zhou | R. Malekzadeh | Y. Teo | M. Coleman | S. Rosso | F. Bray | V. Zadnik | M. Rugge | F. Berrino | R. Cavallo | J. Aitken | H. Sugiyama | S. Eser | M. Rebelo | B. Rachet | G. Roshandel | M. Sekerija | M. Magoni | Wanqing Chen | H. Weir | J. Rashbass | L. Bravo | B. Møller | G. Gatta | J. Bulliard | S. Schwartz | M. Zorzi | S. Gomez | G. Tagliabue | P. Contiero | H. Storm | P. Preux | C. Stiller | A. Chiolero | C. Cirilli | A. Bordoni | V. Bouvier | G. Launoy | K. Matthes | L. Ortelli | S. Rohrmann | R. Tumino | A. Bonaventure | S. Siesling | D. Serraino | P. Arveux | I. Miyashiro | P. Dickman | K. Innos | J. Estève | L. Tryggvadottir | D. Currow | R. Cress | A. Kahn | R. Woods | F. Martínez-Reyes | M. Nishimura | C. Lynch | X. Troussard | F. Merletti | O. Visser | E. Cornet | B. Trétarre | A. Tukiendorf | M. Sant | P. Seghini | A. Katalinic | R. Stabenow | D. Deapen | H. Frick | R. Capocaccia | S. Góźdź | J. Grandpré | L. Antunes | R. Zanetti | M. McKinley | M. Zvolský | A. Stroup | R. Angelis | T. Mierzwa | A. Russo | D. Turhan | B. Holleczek | Y. He | P. Grosclaude | F. Bianconi | G. Tortolero-Luna | L. Keinan-Boker | I. Baldi | X. Zhou | M. Carulla | K. Bendahhou | G. Lim | R. Sassatelli | P. Torres | N. Calleja | M. Michiara | G. Engholm | D. Turner | H. Nakagawa | K. D'onise | Y. Won | C. Allemani | H. Farrugia | C. Bouchardy | M. Colonna | M. Velten | S. Ferretti | S. Larønningen | S. Wiangnon | M. Primic‐Žakelj | B. Edwards | G. Carrozzi | A. D'Argenzio | F. Stracci | T. Matsuda | A. Caiazzo | M. Chirlaque | E. Reca | V. Thursfield | M. Bielska-Lasota | A. Nennecke | G. Sampietro | N. Malila | C. Herrmann | C. Chiang | B. Amadéo | M. Maynadié | J. Zhang | A. Gavin | N. Larrañaga | R. Galasso | I. Oki | F. Falcini | M. Castaing | R. Filiberti | W. Mazzucco | L. Mangone | S. Piffer | S. Carone | A. Melcarne | L. Boschetti | F. Cuccaro | G. Candela | J. Dowling | M. Piñeros | A. L. Munain | G. Coureau | D. Coza | J. Galceran | M. Hackl | N Bossard | Otto Visser | Michel P Coleman | F Bray | U. Wojciechowska | M. Zwierko | O. Ganry | M. Mägi | M. Hattori | Y. Kaizaki | R. Walton | A. Monnereau | J. Clavel | Alain Monnereau | T Freeman | F Bianconi | M D Chirlaque | E Molina | S M Schwartz | Christopher J Johnson | F. Moreno | S. Bouzbid | M. Hamdi-Chérif | C. Lima | C. Uribe | E. Barrios | C. Nikiforuk | M. Macintyre | H. Stuart-Panko | J. Brockhouse | C. Rao | S. Bolick | R. Rycroft | L. Mueller | G. Levin | R. Bayakly | L. Ruppert | T. Tucker | M. Schwenn | S. Gershman | G. Copeland | D. Rogers | D. Lemons | B. Riddle | C. Wiggins | M. Schymura | L. Giljahn | M. Whiteside | A. Johnson | S. Farley | R. Malicki | J. Espinoza | N. Wang | B. Silverman | S. Kanemura | A. Shibata | O. Nimri | K. Jung | R. Buasom | D. Pongnikorn | H. Sriplung | O. Dirican | Z. Valerianova | B. Lacour | A. Guizard | F. Molinié | S. Bara | É. Marrer | P. Walsh | M. Fusco | F. Tisano | J. Didkowska | M. Trojanowski | R. Peris-Bonet | R. Marcos-Gragera | C. Kuehni | I. Konzelmann | H. Phung | J. Hendrix | G Gatta | I Baldi | N Malila | M Piñeros | J Rashbass | J Clavel | Gek Hsiang Lim | J. Kieschke | D. Bradshaw | N. Bossard | A Katalinic | K. Pawlish | F. Vigneau | M Robaszkiewicz | A. Cowppli-Bony | Z. Uhry | A. Woronoff | M. Nikšić | D. L. Rousseau | G Gola | N Eisemann | Gulnar Azevedo e Silva | Tomohiro Matsuda | C Navarro | M Rugge | I Miyashiro | Claudia Allemani | D Currow | S Bouzbid | Hannah K Weir | Sergio L Vargas | J. Jegu | J. Deloumeaux | T. Beran | R. Borchers | F. Vittadello | D Bradshaw | F. Khan | M. Chamorro | Joanne Aitken | A. Ardizzone | C. Pouchieu | T. Cassetti | K. Drosik | C F Lynch | S Rosso | R Zanetti | G. Alverson | Gerda Engholm | A V Guizard | X Troussard | G Launoy | G Tortolero-Luna | C. A. McClure | R Galasso | F Pannozzo | G Grosso | C Bouchardy | L Keinan-Boker | N. Eisemann | A. Eberle | K. Emrich | E. Sirri | S. Kwong | M. Gentilini | Sultan Eser | M Velten | Q. L. Li | R Capocaccia | A Mariotto | N Larrañaga | P Grosclaude | N. Fukushima | P M Preux | P. Sgargi | A. Zucchetto | A Chiolero | C. Ochir | R Schaffar | P Delafosse | F Molinié | S Bara | B Trétarre | M Maynadié | P Arveux | S Piffer | O Ganry | D Turner | S. Zeissig | M. Williams | F. Pannozzo | Christopher J. Johnson | A Bordoni | I Nakata | L Mangone | S. Plouvier | K. Ligier | D Serraino | F Rharbaoui | J Jackson-Thompson | A Zucchetto | D Deapen | J Galceran | R Marcos-Gragera | A R Kahn | Rhea Harewood | Audrey Bonaventure | Wan-Qing Chen | Olufemi J Ogunbiyi | Y J Won | A. Khater | K Emrich | B Holleczek | A Eberle | R. A. Rego | Veronica Di Carlo | Mikhail Valkov | Charles A Stiller | Ryan R Woods | M Hamdi-Chérif | Z Zaidi | K Meguenni | D Regagba | S Bayo | T Cheick Bougadari | S S Manraj | K Bendahhou | A Fabowale | N I M Somdyala | I Kumcher | F Moreno | G H Calabrano | S B Espinola | B Carballo Quintero | R Fita | M C Diumenjo | W D Laspada | S G Ibañez | C A Lima | P C F De Souza | K Del Pino | C Laporte | M P Curado | J C de Oliveira | C L A Veneziano | D B Veneziano | M R D O Latorre | L F Tanaka | M S Rebelo | M O Santos | J C Galaz | M Aparicio Aravena | J Sanhueza Monsalve | D A Herrmann | S Vargas | V M Herrera | C J Uribe | L E Bravo | L S Garcia | N E Arias-Ortiz | D Morantes | D M Jurado | M C Yépez Chamorro | S Delgado | M Ramirez | Y H Galán Alvarez | P Torres | F Martínez-Reyes | L Jaramillo | R Quinto | J Castillo | M Mendoza | P Cueva | J G Yépez | B Bhakkan | J Deloumeaux | C Joachim | J Macni | R Carrillo | J Shalkow Klincovstein | R Rivera Gomez | E Poquioma | D Zavala | R Alonso | E Barrios | A Eckstrand | C Nikiforuk | G Noonan | E Kumar | B Zhang | F R McCrate | S Ryan | M MacIntyre | N Saint-Jacques | D E Nishri | C A McClure | K A Vriends | S Kozie | H Stuart-Panko | J T George | J T Brockhouse | D K O'Brien | A Holt | L Almon | S Kwong | C Morris | R Rycroft | L Mueller | C E Phillips | H Brown | B Cromartie | A G Schwartz | F Vigneau | G M Levin | B Wohler | R Bayakly | K C Ward | S L Gomez | M McKinley | R Cress | M D Green | K Miyagi | L P Ruppert | B Huang | T C Tucker | L Liu | M C Hsieh | X C Wu | M Schwenn | S T Gershman | R C Knowlton | G Alverson | G E Copeland | S Bushhouse | D B Rogers | D Lemons | H J Zimmerman | M Hood | J Roberts-Johnson | J R Rees | B Riddle | K S Pawlish | A Stroup | C Key | C Wiggins | M J Schymura | S Radhakrishnan | C Rao | L K Giljahn | R M Slocumb | R E Espinoza | F Khan | K G Aird | T Beran | J J Rubertone | S J Slack | L Garcia | D L Rousseau | T A Janes | S W Bolick | D M Hurley | M A Whiteside | P Miller-Gianturco | M A Williams | K Herget | C Sweeney | A T Johnson | M B Keitheri Cheteri | P Migliore Santiago | S E Blankenship | S Farley | R Borchers | R Malicki | J R Espinoza | J Grandpre | R Wilson | B K Edwards | Y Lei | N Wang | J S Chen | Y Zhou | Y T He | G H Song | X P Gu | D Mei | H J Mu | H M Ge | T H Wu | Y Y Li | D L Zhao | F Jin | J H Zhang | F D Zhu | Q Junhua | Y L Yang | C X Jiang | W Biao | Q L Li | H Yi | J Dong | W Li | F X Fu | S Z Liu | J G Chen | J Zhu | Y Q Lu | M Fan | S Q Huang | G P Guo | H Zhaolai | K Wei | H Zeng | A V Demetriou | W K Mang | K C Ngan | A C Kataki | M Krishnatreya | P A Jayalekshmi | P Sebastian | A Nandakumar | R Malekzadeh | G Roshandel | B G Silverman | H Ito | H Nakagawa | M Sato | F Tobori | N Teramoto | M Hattori | Y Kaizaki | F Moki | H Sugiyama | M Utada | M Nishimura | K Yoshida | K Kurosawa | Y Nemoto | H Narimatsu | M Sakaguchi | S Kanemura | M Naito | R Narisawa | K Nakata | S Sato | M Yoshii | N Fukushima | A Shibata | K Iwasa | C Ono | O Nimri | K W Jung | E Alawadhi | A Elbasmi | A Ab Manan | F Adam | E Sanjaajmats | U Tudev | C Ochir | A M Al Khater | M M El Mistiri | Y Y Teo | C J Chiang | W C Lee | R Buasom | S Sangrajrang | S Kamsa-ard | S Wiangnon | K Daoprasert | D Pongnikorn | A Leklob | S Sangkitipaiboon | S L Geater | H Sriplung | O Ceylan | I Kög | O Dirican | T Köse | T Gurbuz | F E Karaşahin | D Turhan | U Aktaş | Y Halat | C I Yakut | M Altinisik | Y Cavusoglu | A Türkköylü | N Üçüncü | M Hackl | A A Zborovskaya | O V Aleinikova | K Henau | L Van Eycken | Z Valerianova | M R Yordanova | M Šekerija | L Dušek | M Zvolský | H Storm | K Innos | M Mägi | K Seppä | J Jégu | E Cornet | A M Bouvier | V Bouvier | M Mounier | A S Woronoff | M Daoulas | S Goujon | B Lacour | C Pouchieu | B Amadeo | G Coureau | S Orazio | E Marrer | K Ligier | S Plouvier | A Cowppli-Bony | B Lapôtre-Ledoux | Z Uhry | R Stabenow | H Wilsdorf-Köhler | S Luttmann | I Löhden | A L Nennecke | J Kieschke | E Sirri | S R Zeissig | R A Asquez | V Kumar | E Petridou | E J Ólafsdóttir | L Tryggvadóttir | K Clough-Gorr | P M Walsh | H Sundseth | G Mazzoleni | F Vittadello | E Coviello | F Cuccaro | G Sampietro | A Giacomin | M Magoni | A Ardizzone | A D'Argenzio | M Castaing | A M Lavecchia | A Sutera Sardo | L Gatti | P Ricci | S Ferretti | M V Celesia | R A Filiberti | A Melcarne | F Quarta | A G Russo | C Cirilli | L Cavalieri d'Oro | M Rognoni | M Fusco | M F Vitale | M Usala | R Cusimano | M Michiara | P Sgargi | L Boschetti | E Borciani | P Seghini | M M Maule | P Mancuso | M Vicentini | T Cassetti | R Sassatelli | F Falcini | S Giorgetti | A L Caiazzo | R Cavallo | R Cesaraccio | D R Pirino | M L Contrino | F Tisano | A C Fanetti | S Maspero | S Carone | A Mincuzzi | G Candela | T Scuderi | M A Gentilini | A Barchielli | A Caldarella | F Stracci | M Zorzi | S Beggiato | A Brustolin | M Sant | C Buzzoni | R De Angelis | A Maurina | S Pildava | N Lipunova | I Vincerževskiené | D Agius | N Calleja | S Larønningen | A Dyzmann-Sroka | M Trojanowski | S Góźdź | R Mężyk | T Mierzwa | L Molong | J Rachtan | S Szewczyk | J Błaszczyk | K Kępska | B Kościańska | K Tarocińska | M Zwierko | K Drosik | K M Maksimowicz | E Purwin-Porowska | E Reca | J Wójcik-Tomaszewska | A Tukiendorf | M Grądalska-Lampart | A U Radziszewska | M Talerczyk | M Wyborska | J A Didkowska | U Wojciechowska | M Bielska-Lasota | G Forjaz de Lacerda | R A Rego | J Bastos | M A Silva | L Antunes | J Laranja Pontes | A Mayer-da-Silva | A Miranda | L M Blaga | D Coza | L Gusenkova | O Lazarevich | O Prudnikova | D M Vjushkov | A G Egorova | A E Orlov | L A Kudyakov | L V Pikalova | J Adamcik | C Safaei Diba | M Primic-Žakelj | V Zadnik | A Lopez de Munain | A A Herrera | R Redondas | M L Vilardell Gil | M J Sánchez Perez | P Franch Sureda | M Ramos Montserrat | E E Ardanaz | M M Guevara | R Fernández-Delgado | R Peris-Bonet | M Carulla | C Alberich | M Vicente-Raneda | S Khan | D Pettersson | P Dickman | I Avelina | K Staehelin | B Camey | H Frick | C Herrmann | J L Bulliard | M Maspoli-Conconi | C E Kuehni | S M Redmond | L Ortelli | I Konzelmann | K L Matthes | J Broggio | D Fitzpatrick | D I Clark | A J Deas | D W Huws | C White | L Montel | A D Turculet | R Stephens | E Chalker | H Phung | R Walton | H You | S Guthridge | F Johnson | P Gordon | K D'Onise | K Priest | B C Stokes | A Venn | H Farrugia | V Thursfield | J Dowling | J Hendrix | C Lewis | F. Karaşahin | R. Cesaraccio | D. Fitzpatrick | P. Cueva | K. Daoprasert | N. Saint-Jacques | S. Pildava | O. Aleinikova | K. Seppä | S. Luttmann | S. Redmond | M. Hsieh | N. Lipunova | K. Priest | K. Henau | D. I. Clark | R. Schaffar | R. Cusimano | U. Tudev | J. Broggio | G. A. Silva | A. Elbasmi | C. Navarro | T. Gurbuz | M. Utada | J. Rees | F. Fu | F. Jin | K. Nakata | M. Valkov | K. Meguenni | D. Regagba | S. Bayo | S. Manraj | O. Ogunbiyi | R. Fita | C. Laporte | C. Veneziano | L. García | N. Arias-Ortiz | D. Jurado | B. Bhakkan | C. Joachim | J. Macni | E. Poquioma | D. Zavala | R. Alonso | A. Eckstrand | G. Noonan | S. Kozie | L. Almon | B. Wohler | R. Knowlton | H. Zimmerman | J. Roberts-Johnson | S. Radhakrishnan | R. Slocumb | K. Herget | C. Sweeney | D. Zhao | M. Fan | G. Guo | H. Zhaolai | W. K. Mang | M. Krishnatreya | P. Jayalekshmi | A. Nandakumar | F. Tobori | I. Nakata | F. Moki | R. Narisawa | E. Alawadhi | A. Leklob | S. Sangkitipaiboon | I. Kög | Y. Halat | C. Yakut | A. Türkköylü | A. Zborovskaya | M. Mounier | M. Daoulas | P. Delafosse | B. Lapôtre-Ledoux | H. Wilsdorf-Köhler | I. Löhden | R. Asquez | H. Sundseth | E. Coviello | G. Gola | F. Quarta | P. Mancuso | M. Vicentini | S. Giorgetti | S. Maspero | A. Mincuzzi | T. Scuderi | A. Caldarella | A. Brustolin | A. Maurina | I. Vincerzevskiene | J. Rachtan | K. Kępska | B. Kościańska | J. Wójcik-Tomaszewska | A. Mayer-da-Silva | L. Gusenkova | O. Lazarevich | O. Prudnikova | D. M. Vjushkov | K. Staehelin | M. Maspoli-Conconi | M. Matz | E. Chalker | H. You | K. Clough-Gorr | E. Molina | M. Curado | R. Harewood | Z. Zaidi | T. C. Bougadari | A. Fabowale | N. Somdyala | I. Kumcher | G. Calabrano | S. Espinola | B. C. Quintero | M. Diumenjo | W. Laspada | S. Ibañez | P. C. Souza | K. D. Pino | J. C. D. Oliveira | D. Veneziano | M. Latorre | L. F. Tanaka | M. O. Santos | J. Galaz | M. Aravena | J. S. Monsalve | D. Herrmann | V. Herrera | D. Morantes | S. Delgado | M. Ramirez | Y. G. Álvarez | L. Jaramillo | R. Quinto | J. Castillo | M. Mendoza | J. G. Yépez | R. Carrillo | J. S. Klincovstein | R. Gómez | E. Kumar | B. Zhang | F. McCrate | S. Ryan | D. Nishri | K. Vriends | T. Freeman | J. George | D. O’Brien | A. Holt | C. Morris | C. Phillips | H. Brown | B. Cromartie | A. Schwartz | K. Ward | M. Green | K. Miyagi | B. Huang | L. Liu | X. C. Wu | S. Bushhouse | J. Jackson-Thompson | M. Hood | C. Key | R. Espinoza | K. G. Aird | J. Rubertone | S. Slack | T. Janes | D. Hurley | P. Miller-Gianturco | M. K. Cheteri | P. M. Santiago | S. Blankenship | R. Wilson | A. Mariotto | Y. Lei | J. S. Chen | Y. Zhou | G. Song | X. Gu | D. Mei | H. Mu | H. Ge | T. H. Wu | Y. Y. Li | F. Zhu | Q. Junhua | Y. L. Yang | C. Jiang | W. Biao | J. Wang | H. Yi | J. Dong | W. Li | S. Z. Liu | J. G. Chen | J. Zhu | Y. H. Li | Y. Lu | S. Q. Huang | K. Wei | H. Zeng | A. Demetriou | K. Ngan | A. Kataki | P. Sebastián | H. Ito | M. Sato | N. Teramoto | K. Yoshida | K. Kurosawa | Y. Nemoto | H. Narimatsu | M. Sakaguchi | M. Naito | S. Sato | M. Yoshii | K. Iwasa | C. Ono | A. A. Manan | F. Adam | E. Sanjaajmats | M. E. Mistiri | W. C. Lee | S. Sangrajrang | S. Kamsa-ard | S. Geater | O. Ceylan | T. Köse | U. Aktaş | M. Altinişik | Y. Cavusoglu | N. Üçüncü | L. V. Eycken | M. Yordanova | L. Dusek | A. Bouvier | M. Robaszkiewicz | S. Goujon | S. Orazio | F. Rharbaoui | V. Kumar | E. Petridou | E. Ólafsdóttir | G. Mazzoleni | A. Giacomin | G. Grosso | A. Lavecchia | A. Sardo | L. Gatti | P. Ricci | M. Celesia | L. C. D'oro | M. Rognoni | M. Vitale | M. Usala | E. Borciani | M. Maule | D. Pirino | M. Contrino | A. Fanetti | A. Barchielli | S. Beggiato | C. Buzzoni | D. Agius | A. Dyzmann-Sroka | R. Mężyk | L. Molong | S. Szewczyk | J. Błaszczyk | K. Tarocińska | K. M. Maksimowicz | E. Purwin-Porowska | M. Grądalska-Lampart | A. Radziszewska | A. Gos | M. Talerczyk | M. Wyborska | G. F. Lacerda | J. Bastos | M. A. Silva | J. Pontes | A. Miranda | L. Blaga | A. G. Egorova | A. E. Orlov | L. A. Kudyakov | L. V. Pikalova | J. Adamcik | C. Diba | A. A. Herrera | R. Redondas | M. Gil | M. J. Perez | P. Sureda | M. Montserrat | E. Ardanaz | M. M. Guevara | R. Fernández-Delgado | C. Alberich | M. Vicente-Raneda | S. Khan | D. Pettersson | I. Avelina | B. Camey | A. Deas | D. Huws | C. White | L. Montel | A. Turculet | R. Stephens | S. Guthridge | F. Johnson | P. Gordon | B. Stokes | A. Venn | C. Lewis | M. L. Contrino | M. MacIntyre | M. Maynadie | C. A. Lima | C. McClure | N. Wang | S. Huang | W. Lee | K. D'Onise | S. Huang | M. Altınışık | V. Kumar | B. Zhang | G. Silva | M. Šekerija | V. Kumar | K. D’Onise | V. Kumar | V. Kumar | V. D. Carlo | C. S. Diba | R. Fernández‐Delgado | M. K. Cheteri | Y. Q. Lu | B. Lapôtre‐Ledoux | S. G. Ibañez | N. Arias-Ortiz | D. Zhao | L. C. d’Oro | M. Williams | J. Dong

[1]  Joseph Berkson,et al.  Survival Curve for Cancer Patients Following Treatment , 1952 .

[2]  The Natural Duration of Lung Cancer. , 1955, Canadian Medical Association journal.

[3]  F. Ederer,et al.  Maximum utilization of the life table method in analyzing survival. , 1958, Journal of chronic diseases.

[4]  P. Trott,et al.  International Classification of Diseases for Oncology , 1977 .

[5]  M. Moeschberger,et al.  Survival Models and Data Analysis , 1980 .

[6]  M. Stoto,et al.  A reducible four-parameter system of model life tables. , 1983, Population studies.

[7]  C. Stiller,et al.  Trends in survival for childhood cancer in Britain diagnosed 1971-85. , 1990, British Journal of Cancer.

[8]  O. M. Jensen,et al.  Cancer Registration: Principles and Methods , 1991 .

[9]  J. Estève,et al.  Statistical methods in cancer research. Volume IV. Descriptive epidemiology. , 1998, IARC scientific publications.

[10]  E. Kramárová,et al.  The international classification of childhood cancer , 1996, International journal of cancer.

[11]  O. Gefeller,et al.  An alternative approach to monitoring cancer patient survival. , 1996, Cancer.

[12]  A. Engeland,et al.  Relative survival of cancer patients--a comparison between Denmark and the other Nordic countries. , 1998, Acta oncologica.

[13]  J. Cookson.  Cancer survival , 2000, The Lancet.

[14]  James Cochrane.  Zidovudine's patent history , 2000, The Lancet.

[15]  R. Capocaccia,et al.  Life expectancy and cancer survival in the EUROCARE-3 cancer registry areas. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[16]  H. Brenner,et al.  Combining cohort and period methods for retrospective time trend analyses of long-term cancer patient survival rates , 2003, British Journal of Cancer.

[17]  M. Coleman,et al.  Survival of cancer patients in europe—The EUROCARE study , 1995, Cancer Causes & Control.

[18]  Mike Quinn,et al.  Standard cancer patient population for age standardising survival ratios. , 2004, European journal of cancer.

[19]  Eva Steliarova-Foucher,et al.  International Classification of Childhood Cancer, third edition , 2005, Cancer.

[20]  P. Dickman,et al.  Interpreting trends in cancer patient survival , 2006, Journal of internal medicine.

[21]  C. AbouZahr,et al.  A scandal of invisibility: making everyone count by counting everyone , 2007, The Lancet.

[22]  D. Weisenburger,et al.  Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph). , 2007, Blood.

[23]  K. Pritchard-Jones,et al.  What can we learn from geographical comparisons of childhood cancer survival? , 2007, British Journal of Cancer.

[24]  K. Yoo.  Cancer control activities in the Republic of Korea. , 2008, Japanese journal of clinical oncology.

[25]  H. Storm,et al.  [Cancer survival before and after initiating the Danish Cancer Control plan]. , 2008, Ugeskrift for laeger.

[26]  B Rachet,et al.  What if cancer survival in Britain were the same as in Europe: how many deaths are avoidable? , 2009, British Journal of Cancer.

[27]  C. Grady,et al.  How much is life worth: cetuximab, non-small cell lung cancer, and the $440 billion question. , 2009, Journal of the National Cancer Institute.

[28]  Breakaway : The global burden of cancer — challenges and opportunities , 2009 .

[29]  F. Bray,et al.  Survival of patients diagnosed with cancer in the Nordic countries up to 1999–2003 followed to the end of 2006. A critical overview of the results , 2010, Acta oncologica.

[30]  T. Hakulinen,et al.  Education, survival and avoidable deaths in cancer patients in Finland , 2010, British Journal of Cancer.

[31]  Adele Seniori Costantini,et al.  InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2008): update and future directions. , 2010, Blood.

[32]  F. Berrino,et al.  Manual for coding and reporting haematological malignancies. , 2010, Tumori.

[33]  Karol Sikora,et al.  Delivering affordable cancer care in high-income countries. , 2011, The Lancet. Oncology.

[34]  S. Gupta,et al.  Abandonment of treatment for childhood cancer: position statement of a SIOP PODC Working Group. , 2011, The Lancet. Oncology.

[35]  Eric J Feuer,et al.  Projections of the cost of cancer care in the United States: 2010-2020. , 2011, Journal of the National Cancer Institute.

[36]  H. Tsukuma,et al.  Role of age and tumour stage in the temporal pattern of 'cure' from stomach cancer: a population-based study in Osaka, Japan. , 2012, Cancer epidemiology.

[37]  M. Coleman,et al.  How many deaths would be avoidable if socioeconomic inequalities in cancer survival in England were eliminated? A national population-based study, 1996-2006. , 2012, European journal of cancer.

[38]  T. Hakulinen,et al.  Avoidable deaths and random variation in patients' survival , 2012, British Journal of Cancer.

[39]  B. Rachet,et al.  Cure by age and stage at diagnosis for colorectal cancer patients in North West England, 1997-2004: a population-based study. , 2012, Cancer epidemiology.

[40]  C. Mathers,et al.  Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions , 2012, The Lancet.

[41]  Janez Stare,et al.  On Estimation in Relative Survival , 2012, Biometrics.

[42]  M. Coleman,et al.  Full dates (day, month, year) should be used in population‐based cancer survival studies , 2012, International journal of cancer.

[43]  R. Atun,et al.  Closing the Cancer Divide: An Equity Imperative , 2012 .

[44]  G. Gatta,et al.  Survival and cure trends for European children, adolescents and young adults diagnosed with acute lymphoblastic leukemia from 1982 to 2002 , 2013, Haematologica.

[45]  Jacques Ferlay,et al.  GLOBOCAN 2012: Estimated cancer incidence, mortality and prevalence worldwide in 2012 , 2013 .

[46]  E. Steliarova-Foucher,et al.  New policies to address the global burden of childhood cancers. , 2013, The Lancet. Oncology.

[47]  M. Coleman,et al.  Stage at diagnosis and colorectal cancer survival in six high-income countries: A population-based study of patients diagnosed during 2000–2007 , 2013, Acta oncologica.

[48]  Alan D. Lopez,et al.  Civil registration and vital statistics—everybody's business but nobody's business , 2013, The Lancet.

[49]  E. Steliarova-Foucher,et al.  Paediatric cancer in low-income and middle-income countries. , 2013, The Lancet. Oncology.

[50]  M. Lai,et al.  Improving but Inferior Survival in Patients with Chronic Lymphocytic Leukemia in Taiwan: A Population-Based Study, 1990–2004 , 2013, PloS one.

[51]  M. Coleman,et al.  Colorectal cancer survival in the USA and Europe: a CONCORD high-resolution study , 2013, BMJ Open.

[52]  M. Coleman.  Cancer survival: global surveillance will stimulate health policy and improve equity , 2014, The Lancet.

[53]  P. Lambert,et al.  Estimating the cure proportion of malignant melanoma, an alternative approach to assess long term survival: a population-based study. , 2014, Cancer epidemiology.

[54]  B. Møller,et al.  Years of life lost as a measure of cancer burden on a national level , 2014, British Journal of Cancer.

[55]  L. Gossner,et al.  Long-term efficacy and safety of endoscopic resection for patients with mucosal adenocarcinoma of the esophagus. , 2014, Gastroenterology.

[56]  Michel Grzebyk,et al.  Net Survival Estimation with Stns , 2014 .

[57]  Hamid Mahmoodi,et al.  Impact of Documentation Errors on Accuracy of Cause of Death Coding in an Educational Hospital in Southern Iran , 2014, Health information management : journal of the Health Information Management Association of Australia.

[58]  E. Emanuel,et al.  Public health, universal health coverage, and Sustainable Development Goals: can they coexist? , 2015, The Lancet.

[59]  Y. Suh,et al.  Screening and Early Detection of Gastric Cancer: East Versus West. , 2015, The Surgical clinics of North America.

[60]  Asem Mansour,et al.  Cancer care in Jordan. , 2015, Hematology/oncology and stem cell therapy.

[61]  M. Coleman,et al.  Is England closing the international gap in cancer survival? , 2015, British Journal of Cancer.

[62]  M. Coleman,et al.  How many cancer deaths could New Zealand avoid if five‐year relative survival ratios were the same as in Australia? , 2015, Australian and New Zealand journal of public health.

[63]  P. Prorok,et al.  Conceptualizing overdiagnosis in cancer screening. , 2015, Journal of the National Cancer Institute.

[64]  I. Choi,et al.  Effect of endoscopy screening on stage at gastric cancer diagnosis: results of the National Cancer Screening Programme in Korea , 2014, British Journal of Cancer.

[65]  J. Warren,et al.  Global survival patterns: potential for cancer control , 2015, The Lancet.

[66]  Michael Baumann,et al.  Expanding global access to radiotherapy. , 2015, The Lancet. Oncology.

[67]  Independent Cancer Taskforce.  Achieving world-class cancer outcomes: a strategy for England 2015-2020 , 2015 .

[68]  A. Gawande,et al.  Global Surgery 2030: evidence and solutions for achieving health, welfare, and economic development , 2015, The Lancet.

[69]  Helena Carreira,et al.  Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2) , 2015, The Lancet.

[70]  C. Mathers,et al.  Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.

[71]  B. Rachet,et al.  Multivariable flexible modelling for estimating complete, smoothed life tables for sub-national populations , 2015, BMC Public Health.

[72]  B. Rachet,et al.  No ‘cure’ within 12 years of diagnosis among breast cancer patients who are diagnosed via mammographic screening: women diagnosed in the West Midlands region of England 1989–2011 , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

[73]  M. Mirzaei,et al.  Expected Years of Life Lost Due to Adult Cancer Mortality in Yazd ( 2004-2010 ). , 2016, Asian Pacific journal of cancer prevention : APJCP.

[74]  M. Tsironi,et al.  The quality of death certification practice in Greece. , 2016, Hippokratia.

[75]  J. Ferlay,et al.  An assessment of GLOBOCAN methods for deriving national estimates of cancer incidence , 2016, Bulletin of the World Health Organization.

[76]  Sujha Subramanian,et al.  Cost of Operating Central Cancer Registries and Factors That Affect Cost: Findings From an Economic Evaluation of Centers for Disease Control and Prevention National Program of Cancer Registries. , 2016, Journal of public health management and practice : JPHMP.

[77]  S. L. Stewart,et al.  Population‐based cancer survival (2001 to 2009) in the United States: Findings from the CONCORD‐2 study , 2017, Cancer.

[78]  E. Trimble,et al.  Changing global policy to deliver safe, equitable, and affordable care for women’s cancers , 2017, The Lancet.

[79]  C. Yip,et al.  What If All Patients with Breast Cancer in Malaysia Have Access to the Best Available Care: How Many Deaths Are Avoidable? , 2017 .

[80]  N. Yamazaki,et al.  Sunrise in melanoma management: Time to focus on melanoma burden in Asia , 2017, Asia-Pacific journal of clinical oncology.

[81]  M. Coleman,et al.  Population‐based cancer survival in the United States: Data, quality control, and statistical methods , 2017, Cancer.

[82]  Richard Sullivan,et al.  The global burden of women’s cancers: a grand challenge in global health , 2017, The Lancet.

[83]  O. Brawley.  Accepting the Existence of Breast Cancer Overdiagnosis , 2017, Annals of Internal Medicine.

[84]  C. D. Cunha,et al.  Avaliação da investigação de óbitos por causas mal definidas no Brasil em 2010 , 2017 .

[85]  E. França,et al.  Assessment of the investigation of ill-defined causes of death in Brazil in 2010. , 2017, Epidemiologia e servicos de saude : revista do Sistema Unico de Saude do Brasil.

[86]  M. Coleman,et al.  Public health surveillance of cancer survival in the United States and worldwide: The contribution of the CONCORD programme , 2017, Cancer.

[87]  M. Coleman,et al.  The histology of ovarian cancer: worldwide distribution and implications for international survival comparisons (CONCORD-2). , 2017, Gynecologic oncology.

[88]  Tabaré Vázquez,et al.  Beating NCDs can help deliver universal health coverage , 2017, The Lancet.

[89]  D. French,et al.  Sustainable Development Goals , 2021, Encyclopedia of the UN Sustainable Development Goals.